Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522522 · ClinicalTrials.gov registry record
Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
A clinical trial, sponsored by UCB Pharma.
- Completed
- Registry status
- 400
- Enrollment target
NCT00522522 is a clinical trial that has completed, run by UCB Pharma. The registered enrollment target is 400 participants.
The verdict
NCT00522522 has completed, sponsored by UCB Pharma.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
Naturalistic, multicentre, epidemiological study to evaluate the care services used during the process of diagnosis of any kind of epilepsy. Data about services since first seizure until confirmed diagnosis will be examined.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00522522
The ClinicalTrials.gov registry entry for NCT00522522 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCB Pharma, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00522522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00522522 about?
NCT00522522 is a clinical study titled "Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy". Naturalistic, multicentre, epidemiological study to evaluate the care services used during the process of diagnosis of any kind of epilepsy. Data about services since first seizure until confirmed diagnosis will be examined.
What is the current status of trial NCT00522522?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2008-02. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00522522?
This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.